Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Williams

Showing results (231-240 of 417) with videos related to

Pageof 42
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 8, 2019
The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCEAlexandra K Lee, Mark Woodward, Dan Wang, et al.
Journal of Hypertension|August 3, 2017
Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of HypertensionPasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, et al.
Diabetes Care|March 1, 2014
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetesJuuso I Blomster, Sophia Zoungas, John Chalmers, et al.
European Heart Journal|June 7, 2018
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
BMJ Open|August 9, 2015
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trialThomas M MacDonald, Bryan Williams, Mark Caulfield, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 24, 2012
Patients' experiences of self-monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative studyMiren I Jones, Sheila M Greenfield, Emma P Bray, et al.
Journal of Hypertension|March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetesYoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Clinic Versus Daytime Ambulatory Blood Pressure Difference in Hypertensive Patients: The Impact of Age and Clinic Blood PressureJosé R Banegas, Luis M Ruilope, Alejandro de la Sierra, et al.
Clinical Medicine (London, England)|December 4, 2021
'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV)Amitava Banerjee, Laura Pasea, Sinduja Manohar, et al.
Diabetes Care|June 25, 2015
Erratum. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295-303Graham S Hillis, Paul Welsh, John Chalmers, et al.
Pageof 42

Showing results (231-240 of 417) with videos related to

Sort By:
Pageof 42
The Journal of Clinical Endocrinology and Metabolism|October 8, 2019
The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCEAlexandra K Lee, Mark Woodward, Dan Wang, et al.
Journal of Hypertension|August 3, 2017
Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of HypertensionPasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, et al.
Diabetes Care|March 1, 2014
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetesJuuso I Blomster, Sophia Zoungas, John Chalmers, et al.
European Heart Journal|June 7, 2018
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
BMJ Open|August 9, 2015
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trialThomas M MacDonald, Bryan Williams, Mark Caulfield, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 24, 2012
Patients' experiences of self-monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative studyMiren I Jones, Sheila M Greenfield, Emma P Bray, et al.
Journal of Hypertension|March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetesYoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Clinic Versus Daytime Ambulatory Blood Pressure Difference in Hypertensive Patients: The Impact of Age and Clinic Blood PressureJosé R Banegas, Luis M Ruilope, Alejandro de la Sierra, et al.
Clinical Medicine (London, England)|December 4, 2021
'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV)Amitava Banerjee, Laura Pasea, Sinduja Manohar, et al.
Diabetes Care|June 25, 2015
Erratum. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295-303Graham S Hillis, Paul Welsh, John Chalmers, et al.
Pageof 42